Devika Shetty

Devika Shetty is a Marie Curie Doctoral Fellow in the CanDoIt consortium, which integrates 12 multidisciplinary teams to advance breast cancer diagnostics and treatment. She is pursuing her Ph.D. in cancer research, specializing in extracellular vesicles (EVs) and chemoresistance in breast cancer. She holds a Master’s degree in Genome Engineering. Her research expertise lies at the intersection of translational immunology and cancer genomics, with a particular focus on leukemia and lymphoma during her tenure at India’s premier cancer research institute, Tata Memorial Centre. She has also gained hands-on experience with advanced molecular medicine techniques across diverse disease contexts in Germany. Currently, she is engaged in a clinical trial at Oscar Lambret, where her research focuses on chemoresistant extracellular vesicles (EVs) in luminal A and B breast cancer subtypes. Her goal is to develop a biosensor capable of predicting chemoresistance using just a single drop of blood or urine. This innovative approach has the potential to significantly reduce diagnostic time, enabling earlier intervention and improved patient outcomes.Driven by a deep passion for cancer research, she is committed to leveraging her interdisciplinary expertise to bridge the gap between research and clinical applications. Her ultimate vision is to integrate cutting-edge technologies in oncology to develop transformative solutions for the healthcare industry.